BeiGene, Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
270.69
+3.11 (1.16%)
Mar 31, 2025, 10:03 AM EDT - Market open
BeiGene Market Cap
BeiGene has a market cap or net worth of $29.11 billion as of March 31, 2025. Its market cap has increased by 57.78% in one year.
Market Cap
29.11B
Enterprise Value
27.21B
1-Year Change
57.78%
Ranking
Category
Stock Price
$270.69
Market Cap Chart
Since February 3, 2016, BeiGene's market cap has increased from $861.90M to $29.11B, an increase of 3,277.27%. That is a compound annual growth rate of 46.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 28.53B | 44.90% |
| Dec 31, 2024 | 19.69B | 4.41% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.11B |
| UnitedHealth Group | 473.32B |
| Johnson & Johnson | 394.44B |
| AbbVie | 362.65B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 227.98B |
| Merck & Co. | 226.23B |
| AstraZeneca | 225.00B |